{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:21:05Z","timestamp":1787062865546,"version":"build-2736575974"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["NKFIH K-128011"],"award-info":[{"award-number":["NKFIH K-128011"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FIEK_16-1-2016-0005"],"award-info":[{"award-number":["FIEK_16-1-2016-0005"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["VEKOP-2.1.1-15-2016-00117"],"award-info":[{"award-number":["VEKOP-2.1.1-15-2016-00117"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Type 2 diabetes mellitus (T2DM) is a complex metabolic disease and variations in multispecific membrane transporter functions may affect T2DM development, complications or treatment. In this work we have analyzed the potential effects of a major polymorphism, the Q141K variant of the ABCG2 transporter in T2DM. The ABCG2 protein is a multispecific xeno- and endobiotic transporter, affecting drug metabolism and playing a key role in uric acid extrusion. The ABCG2-Q141K variant, with reduced expression level and function, is present in 15\u201335% of individuals, depending on the genetic background of the population, and has been shown to significantly affect gout development. Several other diseases, including hypertension, chronic renal failure, and T2DM have also been reported to be associated with high serum uric acid levels, suggesting that ABCG2 may also play a role in these conditions. In this work we have compared relatively small cohorts (n = 203) of T2DM patients (n = 99) and healthy (n = 104) individuals regarding the major laboratory indicators of T2DM and determined the presence of the SNP\n                    <jats:italic>rs2231142<\/jats:italic>\n                    (\n                    <jats:italic>C421A<\/jats:italic>\n                    ), resulting the ABCG2-Q141K protein variant. We found significantly higher blood glucose and HbA1c levels in the T2DM patients carrying the ABCG2-Q141K variant. These findings may emphasize the potential metabolic role of ABCG2 in T2DM and indicate that further research should explore how prevention and treatment of this disease may be affected by the frequent polymorphism of\n                    <jats:italic>ABCG2<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0260957","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T14:42:53Z","timestamp":1638456173000},"page":"e0260957","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes"],"prefix":"10.1371","volume":"16","author":[{"given":"Edit","family":"Szab\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"M\u00f3zner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Kor\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Liter\u00e1ti-Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Vitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Cserepes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Sarkadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2012-9680","authenticated-orcid":true,"given":"Gy\u00f6rgy","family":"V\u00e1rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"pone.0260957.ref001","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Y Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"pone.0260957.ref002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000480241","article-title":"SLC2A1 Tag SNPs in Greek Patients with Diabetic Retinopathy and Nephropathy","volume":"61","author":"V Siokas","year":"2019","journal-title":"Ophthalmic Res"},{"key":"pone.0260957.ref003","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system","author":"B Sarkadi","year":"2006","journal-title":"Physiological Reviews"},{"key":"pone.0260957.ref004","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1002\/1873-3468.13947","article-title":"The ABCG2\/BCRP transporter and its variants\u2014from structure to pathology","volume":"594","author":"B Sarkadi","year":"2020","journal-title":"FEBS Lett"},{"key":"pone.0260957.ref005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME\u2013Tox)","volume":"13","author":"G Szak\u00e1cs","year":"2008","journal-title":"Drug Discov Today"},{"key":"pone.0260957.ref006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tips.2005.11.007","article-title":"The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins","volume":"27","author":"AE van Herwaarden","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0260957.ref007","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"K Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"pone.0260957.ref008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane","volume":"73","author":"M Huls","year":"2008","journal-title":"Kidney Int"},{"key":"pone.0260957.ref009","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"A Dehghan","year":"2008","journal-title":"Lancet (London, England)"},{"key":"pone.0260957.ref010","doi-asserted-by":"crossref","first-page":"28549","DOI":"10.1038\/srep28549","article-title":"Serum Uric Acid Levels were Dynamically Coupled with Hemoglobin A1c in the Development of Type 2 Diabetes","volume":"6","author":"F Wei","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0260957.ref011","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK\/AKT\/CREB Signaling Pathway in Type 2 Diabetic Mice","volume":"16","author":"Y-H Lu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"pone.0260957.ref012","doi-asserted-by":"crossref","first-page":"21440","DOI":"10.1038\/srep21440","article-title":"Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes","volume":"6","author":"AK Giri","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0260957.ref013","doi-asserted-by":"crossref","first-page":"15471","DOI":"10.4238\/2015.November.30.25","article-title":"Quantitative candidate gene association studies of metabolic traits in Han Chinese type 2 diabetes patients","volume":"14","author":"FJ Wei","year":"2015","journal-title":"Genet Mol Res"},{"key":"pone.0260957.ref014","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1038\/s41598-018-25695-z","article-title":"Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression","volume":"8","author":"B Z\u00e1mb\u00f3","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0260957.ref015","doi-asserted-by":"crossref","first-page":"e48423","DOI":"10.1371\/journal.pone.0048423","article-title":"Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations","volume":"7","author":"I Kasza","year":"2012","journal-title":"PLoS One"},{"key":"pone.0260957.ref016","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jdiacomp.2016.06.002","article-title":"Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus","volume":"30","author":"V Bart\u00e1kov\u00e1","year":"2016","journal-title":"J Diabetes Complications"},{"key":"pone.0260957.ref017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","article-title":"GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes","volume":"76","author":"A Nakayama","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"pone.0260957.ref018","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/pgs.09.85","article-title":"Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin","volume":"10","author":"JE Keskitalo","year":"2009","journal-title":"Pharmacogenomics"},{"key":"pone.0260957.ref019","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41598-021-82417-8","article-title":"Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients","volume":"11","author":"E Szab\u00f3","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0260957.ref020","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020","volume":"43","author":"AD Association","year":"2020","journal-title":"Diabetes Care"},{"key":"pone.0260957.ref021","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","article-title":"The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion","volume":"11","author":"KM Hoque","year":"2020","journal-title":"Nat Commun"},{"key":"pone.0260957.ref022","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11095-008-9752-7","article-title":"Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations","volume":"26","author":"T Furukawa","year":"2009","journal-title":"Pharm Res"},{"key":"pone.0260957.ref023","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1214530110","article-title":"Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules","volume":"110","author":"OM Woodward","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0260957.ref024","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","article-title":"Functional non-synonymous variants of ABCG2 and gout risk","volume":"56","author":"B Stiburkova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0260957.ref025","unstructured":"NIH Accelerating Medicines Partnership. Type 2 Diabetes Knowledge Portal. Http:\/\/Www.Type2Diabetesgenetics.Org. 2014. https:\/\/t2d.hugeamp.org\/"},{"key":"pone.0260957.ref026","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17425255.2019.1591373","article-title":"ABCG2\/BCRP: variants, transporter interaction profile of substrates and inhibitors","volume":"15","author":"Z Safar","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"pone.0260957.ref027","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bcp.12079","article-title":"Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters","volume":"76","author":"B Grun","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0260957.ref028","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","article-title":"Transporters Involved in Metformin Pharmacokinetics and Treatment Response","volume":"106","author":"X Liang","year":"2017","journal-title":"J Pharm Sci"},{"key":"pone.0260957.ref029","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.01.035","article-title":"Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin","volume":"202","author":"SJ Hemauer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0260957.ref030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/FPC.0b013e3283559b22","article-title":"Metformin pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"L Gong","year":"2012","journal-title":"Pharmacogenet Genomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T14:43:27Z","timestamp":1638456207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260957"}},"subtitle":[],"editor":[{"given":"Kanhaiya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260957","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}